OpenURL Connection Search

Select item for more details and to access through your institution.

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin.
Published in:
Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 9, p. 929, doi. 10.1007/s00432-008-0376-4
By:
- Xiaodong Zhu;
- Jiin Leaw;
- Weilie Gu;
- Yiying Qian;
- Hongyu Du;
- Biyun Wang;
- Xiaonan Hong;
- Jiliang Yin
Publication type:
Article
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma.
Published in:
2020
By:
- Shi, Yuankai;
- Song, Yongping;
- Qin, Yan;
- Zhang, Qingyuan;
- Han, Xiaohong;
- Hong, Xiaonan;
- Wang, Dong;
- Li, Wei;
- Zhang, Yang;
- Feng, Jifeng;
- Yang, Jianmin;
- Zhang, Huilai;
- Jin, Chuan;
- Yang, Yu;
- Hu, Jianda;
- Wang, Zhao;
- Jin, Zhengming;
- Su, Hang;
- Wang, Huaqing;
- Yang, Haiyan
Publication type:
Letter
Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large BCell Lymphoma.
Published in:
Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.066
By:
- Guang-Liang Chen;
- Doudou Li;
- Sufen Cao;
- Shiyu Jiang;
- Qunling Zhang;
- Jia Jin;
- Zuguang Xia;
- Yizhen Liu;
- Xiaojian Liu;
- Yanzhe Zhu;
- Yu Chen;
- Lingli Gu;
- Xiaonan Hong;
- Junning Cao;
- Rong Tao;
- Fangfang Lv
Publication type:
Article
Interim PET/CT result is the sole prognostic factor of survival in patients with advanced-stage diffuse large B-cell lymphoma: a subset analysis of a prospective trial.
Published in:
Journal of Radioanalytical & Nuclear Chemistry, 2021, v. 327, n. 1, p. 353, doi. 10.1007/s10967-020-07511-z
By:
- Jin, Jia;
- Liu, Yizhen;
- Zhang, Qunling;
- Xue, Kai;
- Xia, Zuguang;
- Cao, Junning;
- Hong, Xiaonan;
- Guo, Ye;
- Lv, Fangfang
Publication type:
Article
Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.
Published in:
Investigational New Drugs, 2018, v. 36, n. 1, p. 114, doi. 10.1007/s10637-017-0542-0
By:
- Liu, Xin;
- Wang, Huijie;
- Wu, Xianghua;
- Hong, Xiaonan;
- Luo, Zhiguo
Publication type:
Article
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
Published in:
Annals of Hematology, 2012, v. 91, n. 6, p. 837, doi. 10.1007/s00277-011-1375-0
By:
- Li, Xiaoyang;
- Liu, Zhao;
- Cao, Junning;
- Hong, Xiaonan;
- Wang, Jianmin;
- Chen, Fangyuan;
- Wang, Chun;
- Zou, Shanhua;
- Li, Junmin;
- Shen, Zhixiang
Publication type:
Article
A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
Published in:
2017
By:
- Xin Liu;
- Weijian Guo;
- Wen Zhang;
- Jiliang Yin;
- Jun Zhang;
- Xiaodong Zhu;
- Tianshu Liu;
- Zhiyu Chen;
- Biyun Wang;
- Jianhua Chang;
- Fangfang Lv;
- Xiaonan Hong;
- Huijie Wang;
- Jialei Wang;
- Xinmin Zhao;
- Xianghua Wu;
- Jin Li;
- Liu, Xin;
- Guo, Weijian;
- Zhang, Wen
Publication type:
journal article
Prognostic significance of clinical characteristics and 18 Fluorodeoxyglucose-positron emission tomography/computed tomography quantitative parameters in patients with primary mediastinal B-cell lymphoma.
Published in:
Journal of International Medical Research, 2022, v. 50, n. 1, p. 1, doi. 10.1177/03000605211063027
By:
- Liu, Yizhen;
- Jiang, Jinjin;
- Liu, Lianfang;
- Wang, Zezhou;
- Yu, Baohua;
- Xia, Zuguang;
- Zhang, Qunling;
- Ji, Dongmei;
- Liu, Xiaojian;
- Lv, Fangfang;
- Hong, Xiaonan;
- Song, Shaoli;
- Cao, Junning
Publication type:
Article
Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study.
Published in:
Cancer Medicine, 2024, v. 13, n. 16, p. 1, doi. 10.1002/cam4.70142
By:
- Chen, Guang‐Liang;
- Xue, Kai;
- Zhang, Qunling;
- Xia, Zu‐guang;
- Jin, Jia;
- Li, Ran;
- Liu, Yizhen;
- Lv, Fangfang;
- Hong, Xiaonan;
- Li, Xiaoqiu;
- Cao, Junning
Publication type:
Article
Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T‐cell lymphoma patients.
Published in:
Cancer Medicine, 2020, v. 9, n. 15, p. 5400, doi. 10.1002/cam4.3207
By:
- Liu, Yizhen;
- Xue, Kai;
- Xia, Zuguang;
- Jin, Jia;
- Wang, Jiachen;
- Sun, Hui;
- Lv, Fangfang;
- Liu, Xiaojian;
- Cao, Junning;
- Hong, Xiaonan;
- Guo, Ye;
- Ma, Xuejun;
- Zhang, Qunling
Publication type:
Article
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Published in:
European Journal of Haematology, 2010, v. 85, n. 3, p. 243, doi. 10.1111/j.1600-0609.2010.01474.x
By:
- Dongmei Ji;
- Junning Cao;
- Xiaonan Hong;
- Junmin Li;
- Jianmin Wang;
- Fangyuan Chen;
- Chun Wang;
- Shanhua Zou
Publication type:
Article
An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study.
Published in:
Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 515, doi. 10.1007/s00280-011-1728-3
By:
- Wang, Zhonghua;
- Lu, Jingsong;
- Leaw, Shiangjiin;
- Hong, Xiaonan;
- Wang, Jialei;
- Shao, Zhimin;
- Hu, Xichun
Publication type:
Article
Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 2, p. 213, doi. 10.1007/s00280-008-0728-4
By:
- Biyun Wang;
- Wen Zhang;
- Xiaonan Hong;
- Ye Guo;
- Jin Li
Publication type:
Article
Primary results from the double-blind, placebo-controlled, phase 3 SHINE study of ibrutinib in combination with bendamustine-rituximab (BR) and R maintenance as a first-line treatment for older patients with mantle cell lymphoma (MCL).
Published in:
Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
By:
- Jurczak, Wojciech;
- Gouill, Steven Le;
- Jerkeman, Mats;
- Trotman, Judith;
- Zinzani, Pier Luigi;
- Belada, David;
- Boccomini, Carola;
- Flinn, Ian W.;
- Giri, Pratyush;
- Goy, Andre;
- Hamlin, Paul A.;
- Hermine, Olivier;
- Hernández-Rivas, José-ángel;
- Xiaonan Hong;
- Seok Jin Kim;
- Lewis, David;
- Yuko Mishima;
- Özcan, Muhit;
- Perini, Guilherme Fleury;
- Pocock, Christopher
Publication type:
Article
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era.
Published in:
International Journal of Hematology, 2022, v. 116, n. 3, p. 372, doi. 10.1007/s12185-022-03358-0
By:
- Jin, Jia;
- Gui, Ailing;
- Chen, Guangliang;
- Liu, Yizhen;
- Xia, Zuguang;
- Liu, Xiaojian;
- Lv, Fangfang;
- Cao, Junning;
- Hong, Xiaonan;
- Yang, Ling;
- Gu, Juan J.;
- Zhang, Qunling
Publication type:
Article
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera<sup>®</sup>) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial
Published in:
Hematological Oncology, 2022, v. 40, n. 5, p. 930, doi. 10.1002/hon.3054
By:
- Shi, Yuankai;
- Zhang, Qingyuan;
- Hong, Xiaonan;
- Wang, Zhen;
- Gao, Yuhuan;
- Zou, Liqun;
- Cen, Hong;
- Gui, Lin;
- Li, Yufu;
- Feng, Jifeng;
- Wang, Zhao;
- Zhang, Mingzhi;
- Jin, Chuan;
- Zhang, Weihua;
- Hu, Jianda;
- Zheng, Chengyun;
- Zheng, Zhendong;
- Zhang, Liling;
- Chen, Shaoshui;
- Huang, Yunhong
Publication type:
Article
Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Published in:
American Journal of Hematology, 2008, v. 83, n. 10, p. 795, doi. 10.1002/ajh.21256
By:
- Wang, Biyun;
- Li, Xiao-Qiu;
- Ma, Xuejun;
- Hong, Xiaonan;
- Lu, Hongfen;
- Guo, Ye
Publication type:
Article
Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.
Published in:
Cancer Management & Research, 2020, v. 12, p. 5041, doi. 10.2147/CMAR.S260974
By:
- Liu, Yizhen;
- Liu, Yumei;
- Zhao, Ping;
- Zhang, Qunling;
- Liu, Xiaojian;
- Lv, Fangfang;
- Hong, Xiaonan;
- Cao, Junning;
- Xue, Kai
Publication type:
Article
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.
Published in:
2019
By:
- Hong, Xiaonan;
- Song, Yuqin;
- Huang, Huiqiang;
- Bai, Bing;
- Zhang, Huilai;
- Ke, Xiaoyan;
- Shi, Yuankai;
- Zhu, Jun;
- Lu, Guodong;
- Liebscher, Stefan;
- Cai, Chunxiao
Publication type:
journal article
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.
Published in:
2022
By:
- Jin, Jia;
- Ji, Dongmei;
- Xia, Zuguang;
- Xue, Kai;
- Zhang, Qunling;
- Liu, Yizhen;
- Cao, Junning;
- Hong, Xiaonan;
- Gu, Juan J;
- Guo, Ye;
- Lv, Fangfang
Publication type:
journal article
Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma.
Published in:
OncoTargets & Therapy, 2018, v. 11, p. 3869, doi. 10.2147/OTT.S150339
By:
- Jin, Jie;
- Okamoto, Rumiko;
- Yoon, Sung-Soo;
- Shih, Lee-Yung;
- Zhu, Jun;
- Liu, Ting;
- Hong, Xiaonan;
- Pei, Lixia;
- Rooney, Brendan;
- van de Velde, Helgi;
- Huang, Huiqiang
Publication type:
Article
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma.
Published in:
OncoTargets & Therapy, 2017, v. 10, p. 145, doi. 10.2147/OTT.S117007
By:
- Qunling Zhang;
- Junning Cao;
- Kai Xue;
- Xiaojian Liu;
- Dongmei Ji;
- Ye Guo;
- Xiaonan Hong
Publication type:
Article
Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Lesion at Presentation: Case Report and Literature Review.
Published in:
Acta Haematologica, 2012, v. 127, n. 2, p. 124, doi. 10.1159/000334703
By:
- Wang, Huijie;
- Cao, Junning;
- Hong, Xiaonan
Publication type:
Article
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial
Published in:
EJHaem, 2022, v. 3, n. 4, p. 1154, doi. 10.1002/jha2.517
By:
- Zhu, Jun;
- Hong, Xiaonan;
- Song, Yu Qin;
- Hodkinson, Brendan;
- Balasubramanian, Sriram;
- Wang, Songbai;
- Zhang, Qingyuan;
- Shi, Yuankai;
- Huang, Huiqiang;
- Zhang, Huilai;
- Zhu, Yan;
- Shreeve, Stephen Martin;
- Sun, Steven;
- Wang, Ze;
- Wang, Xiaocan;
- Fan, Yue;
- Wilson, Wyndham;
- Vermeulen, Jessica
Publication type:
Article

Found: 24